(Date:12/3/2009)... Corporation, an innovator of advanced optical instruments, announced ... with Harvard University granting Nikon the rights to ... Under the terms of the agreement, Nikon will ... with the N-STORM name. ,, Nikon Corporation ...
(Date:12/3/2009)... Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ... compounds for the treatment of cardiovascular and metabolic disease, ... visit in its Phase 2 FDG-PET clinical trial of ... and was carried out at five sites in the ...
(Date:12/3/2009)... (Nasdaq: PPHM ) today announced that it will release ... 2010 on December 10, 2009 at 7:00 a.m. EST and ... results at 11:30 a.m. EST on the same day. ,, ... quarter ended October 31, 2009 and will review recent operating ...
(Date:12/3/2009)... Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: ... services for drug discovery and life sciences research, today ... imaging systems. Living Image software drives the more than ... Living Image 4.0 features advanced spectral unmixing tools to ...
Breaking Biology Technology:Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2... 20 Bionovo, Inc. (Nasdaq: BNVI ) today ... nature of the active compound and mechanism of action for ... made at the 2009 conference of the American Association of ... the following:, , ...
... Wiggins Joins from Biogen Idec -SAN DIEGO, April 20 ... the company as Chief Business Officer. Mr. Wiggins comes ... served as Executive Vice President of Business Development, and was ... will be focusing on commercial planning and business development activities ...
... Psylin Neurosciences Inc., a joint ... Inc. and PsychoGenics, Inc. announced today that it ... PSN0041, for the treatment of depression.(Logo: ... peptide from Amylin,s proprietary polypeptide hormone library, PHORMOL, ...
Other Biology Technology:Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 2Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 3Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer 2Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer 3Psylin Neurosciences Commences Development of Compound for Depression 2Psylin Neurosciences Commences Development of Compound for Depression 3...
...
... to rapidly and reliably amplify unknown genomic ... APAgene provides hassle-free, ready-to use components, at ... are provided in each kit. The Genome ... filling, localized cloning of genomic DNA, isolating ...
N,N'-Methylene-bis-acrylamide, Ultra Pure...
Biology Products: